Arvinas

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$9.25
Previous Close
$9.37
Day Range
$9.10-$9.33
52W Range
$5.93-$37.38
Market Cap
$633.3M
Shares Short
7M

Financials

See more
Revenue (12 Mos)
$263.4M
Revenue Growth (YoY)
196%
Gross Profit (12 Mos)
$263.4M
Diluted EPS
-$2.82

News

See more

Yahoo Finance • 7 days ago

Arvinas Announces Results from the VERITAC-2 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Yahoo Finance • 9 days ago

Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting

Yahoo Finance • 26 days ago

Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation

Yahoo Finance • last month

Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s Diseases

About

CEO
Dr. John G. Houston Ph.D.
CFO
Mr. Andrew R. Saik
Address
5 Science Park, New Haven, CT, United States, 06511
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
430